Xencor
Novartis buys into bispecific antibodies with Xencor deal
Richard Staines
bispecific antibody, cancer, immuno-oncology, Novartis, Xencor
0 Comment
Agreement could add to Novartis’ immuno-oncology pipeline.
X
Novartis buys into bispecific antibodies with Xencor deal
https://pharmaphorum.com/news/novartis-signs-150m-antibody-deal-xencor/